Actualités Avicanna Inc - AVCN | Actions Toronto Stock Exchange

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Avicanna Completes First Delivery of Proprietary Topical Products to Multinational Pharmaceutical Company

TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX:...

Avicanna Reports Q3 2024

9-month revenue of $18.8 million, representing a 75% increase from 2023. Consolidated Gross Margins of 57...

Avicanna Announces Closing of Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE...

Avicanna Announces Medical Cannabis Real World Evidence Study through MyMedi.ca

TORONTO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX:...

Avicanna Announces Repayment of Debentures

TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX:...

Avicanna Announces Closing of Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE...

Avicanna Announces United States Patent and Trademark Office Issuance of Patent on Topical Technology

USPTO issues Patent No. US 20230025693A1 (“Patent”) that covers Avicanna’s deep penetrating topicalcannabinoid...

Avicanna Subsidiary Completes Export of Aureus Branded CBG into Denmark

TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX:...

Avicanna Reports Q2 2024

Q2 2024 revenue of $6.1 million an increase of 85% over Q2 2023Completion of two real world evidence trials on...

Avicanna Announces Changes of Auditors

TORONTO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX:...

Avicanna Subsidiary Completes Export of Aureus Branded CBG into Singapore

This marks the first export into Asia, the 18th international market for Aureus branded products and 21st...

Avicanna Announces Results of Annual General Meeting & Provides Corporate Update

TORONTO, July 10, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX:...

Life Science Virtual Investor Forum Presentations Now Available for Online Viewing

NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor...

Avicanna General Meeting

TORONTO, June 19, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX:...

Avicanna Announces USPTO Issuance of Patent SEDDS Technology

TORONTO, June 19, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Avicanna Inc (AVCN)

Outils de qualité professionnelle, pour des investisseurs individuels.

AVCN Actualités

Avicanna Completes First Delivery of Proprietary Topical Products to Multinational Pharmaceutical Company

Avicanna Reports Q3 2024

Avicanna Announces Closing of Non-Brokered Private Placement

Avicanna Announces Medical Cannabis Real World Evidence Study through MyMedi.ca

Avicanna Announces Repayment of Debentures

Avicanna Announces Closing of Non-Brokered Private Placement

Avicanna Announces United States Patent and Trademark Office Issuance of Patent on Topical Technology

Avicanna Subsidiary Completes Export of Aureus Branded CBG into Denmark

Avicanna Reports Q2 2024

Avicanna Announces Changes of Auditors

Avicanna Subsidiary Completes Export of Aureus Branded CBG into Singapore

Avicanna Announces Results of Annual General Meeting & Provides Corporate Update

Life Science Virtual Investor Forum Presentations Now Available for Online Viewing

Avicanna General Meeting

Avicanna Announces USPTO Issuance of Patent SEDDS Technology

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Avicanna Inc (AVCN) Actualités

Avicanna Inc (AVCN)

Outils de qualité professionnelle, pour des investisseurs individuels.

AVCN Actualités

Avicanna Completes First Delivery of Proprietary Topical Products to Multinational Pharmaceutical Company

Avicanna Reports Q3 2024

Avicanna Announces Closing of Non-Brokered Private Placement

Avicanna Announces Medical Cannabis Real World Evidence Study through MyMedi.ca

Avicanna Announces Repayment of Debentures

Avicanna Announces Closing of Non-Brokered Private Placement

Avicanna Announces United States Patent and Trademark Office Issuance of Patent on Topical Technology

Avicanna Subsidiary Completes Export of Aureus Branded CBG into Denmark

Avicanna Reports Q2 2024

Avicanna Announces Changes of Auditors

Avicanna Subsidiary Completes Export of Aureus Branded CBG into Singapore

Avicanna Announces Results of Annual General Meeting & Provides Corporate Update

Life Science Virtual Investor Forum Presentations Now Available for Online Viewing

Avicanna General Meeting

Avicanna Announces USPTO Issuance of Patent SEDDS Technology

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application